Target intelligence / Profile preview

Tetraspanin-6 (TSPAN6)

Target
TSPAN6
Molecular classification
Tetraspanin family, Membrane protein, Four-pass transmembrane protein, Scaffold protein, Other (cell surface glycoprotein)
01

Overview

Tetraspanin-6 is a glycosylated, small integral membrane protein found on the cell surface, encoded by the human TSPAN6 gene. It possesses four highly hydrophobic and conserved transmembrane domains (TM1–TM4), interconnected by one small and one large extracellular loop (EC1 and EC2), with short N- and C-terminal cytoplasmic tails. Tetraspanin-6 acts as a molecular scaffold organizing protein networks in membrane microdomains, facilitating interactions between cell surface receptors, integrins, and signaling molecules. It participates in numerous cellular processes, including cell proliferation, adhesion, migration, signaling, and membrane compartmentalization. Tetraspanin-6’s decreased expression is associated with poor prognosis in colorectal cancer and correlates with reduced sensitivity to EGFR-targeted therapies. It is beginning to be appreciated as a tumor suppressor and predictive biomarker for Cetuximab therapy in colorectal cancer.

Other names
TSPAN6Transmembrane 4 superfamily member 6TM4SF6
02

Mechanism of action

Modulation of EGFR-based signaling by regulating secretion and distribution of TGF-α (tumor suppressor function); Acts via protein complex formation with syntenin-1 and transmembrane TGF-α

03

Biological functions

Cell signal transductionScaffold for signaling proteinsOrganization of membrane microdomainsRegulation of cell development, activation, growth, and motilityCell proliferationCell migrationCell adhesionMembrane fusion and aggregation
04

Disease associations

Cancer (notably colorectal cancer; also implicated in breast and lung cancer)MetastasisPotential role in immune response
05

Safety considerations

Understudied; functional characterization is incompleteNo specific safety concerns or therapeutic challenges have been well-documented
06

Interacting drugs

Cetuximab
07

Biomarkers

Tetraspanin-6 expression level is a predictive biomarker for response to EGFR-targeted therapy (Cetuximab) in colorectal cancer

Beyond the preview

Go deeper on Tetraspanin-6 (TSPAN6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetraspanin-6 (TSPAN6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call